Can chatting with others and AI help breast cancer patients feel less anxious?

NCT ID NCT06604078

Completed Knowledge-focused Sponsor: University of Central Florida Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This completed study from the University of Central Florida involved 199 adults who had breast cancer imaging. Researchers created a social platform called MammoChat where patients could share their experiences anonymously. They also collected de-identified images to train AI models for better detection. The goal was to understand if social support and AI could reduce anxiety and improve outcomes in breast cancer screening.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could point toward a supportive online tool that helps patients feel less anxious during breast cancer screening and aids in developing AI for earlier detection.
What could go wrong: This was a small, completed study focused on building a platform and collecting data, not testing a treatment. The AI models and social network effects need much larger validation before any real-world use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER BREAST CANCER SCREENING

Contacts and locations

Locations

University of Central Florida

Orlando, Florida, 32827, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.